X
Xiaowei Yan
Researcher at Peking Union Medical College Hospital
Publications - 22
Citations - 3503
Xiaowei Yan is an academic researcher from Peking Union Medical College Hospital. The author has contributed to research in topics: Internal medicine & Intensive care unit. The author has an hindex of 10, co-authored 19 publications receiving 2659 citations.
Papers
More filters
Journal ArticleDOI
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.
Yan Zhang,Meng Xiao,Shulan Zhang,Peng Xia,Wei Cao,Wei Jiang,Huan Chen,Xin Ding,Hua Zhao,Hongmin Zhang,Chunyao Wang,Jing Zhao,Xuefeng Sun,Ran Tian,Wei Wu,Dong Wu,Jie Ma,Yu Chen,Dong Zhang,Jing Xie,Xiaowei Yan,Xiang Zhou,Zhengyin Liu,Jinglan Wang,Bin Du,Yan Qin,Peng Gao,Xuzhen Qin,Yingchun Xu,Wen Zhang,Taisheng Li,Fengchun Zhang,Yongqiang Zhao,Yongzhe Li,Shuyang Zhang +34 more
TL;DR: A 69-year-old man with Covid-19 diagnosed in January 2020 in Wuhan, China, along with two other critically ill patients with Covod-19 who were also seen in the same intensive care unit are described.
Journal ArticleDOI
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Wen Zhang,Yan Zhao,Fengchun Zhang,Qian Wang,Tai-sheng Li,Zhengyin Liu,Jinglan Wang,Yan Qin,Xuan Zhang,Xiaowei Yan,Xiaofeng Zeng,Shuyang Zhang +11 more
TL;DR: The clinical and immunological characteristics of severe patients, and the current evidence and share the experience in anti-inflammation treatment of patients with severe COVID-19 that may have an impaired immune system are discussed.
Journal ArticleDOI
Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19.
Jie Ma,Peng Xia,Yangzhong Zhou,Zhengyin Liu,Xiang Zhou,Jinglan Wang,Taisheng Li,Xiaowei Yan,Limeng Chen,Shuyang Zhang,Yan Qin,Xuemei Li +11 more
Journal ArticleDOI
Antiphospholipid Antibodies in Critically Ill Patients With COVID-19.
Meng Xiao,Yan Zhang,Shulan Zhang,Xuzhen Qin,Peng Xia,Wei Cao,Wei Jiang,Huan Chen,Xin Ding,Hua Zhao,Hongmin Zhang,Chunyao Wang,Jing Zhao,Xuefeng Sun,Ran Tian,Wei Wu,Dong Wu,Jie Ma,Yu Chen,Dong Zhang,Jing Xie,Xiaowei Yan,Xiang Zhou,Zhengyin Liu,Jinglan Wang,Bin Du,Yan Qin,Peng Gao,Minya Lu,Xin Hou,Xian Wu,Huadong Zhu,Yingchun Xu,Wen Zhang,Taisheng Li,Fengchun Zhang,Yongqiang Zhao,Yongzhe Li,Shuyang Zhang +38 more
TL;DR: Multiple medium or high levels aPLs may help identify patients at risk of developing cerebral infarction and may trigger the development of “COVID‐19‐induced‐APS‐like‐syndrome”, which is one of the characteristics of critically ill patients with Coronavirus Disease 2019.
Journal ArticleDOI
Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
Yan Zhang,Wei Cao,Wei Jiang,Meng Xiao,Yongzhe Li,Ning Tang,Zhengyin Liu,Xiaowei Yan,Yongqiang Zhao,Taisheng Li,Tienan Zhu +10 more
TL;DR: Sustained hypercoagulable status and thrombotic events were common in critically ill patients with COVID-19, and the low activities of natural anticoagulants, elevated factor VIII level and the presence of antiphospholipid antibodies, together, may contribute to the etiopathology of coagulopathy in CO VID-19 patients.